statistiche ricercatore

Continente	#
EU - Europa	621
NA - Nord America	514
AS - Asia	397
SA - Sud America	127
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	9
OC - Oceania	4
Totale	1.697

Nazione	#
US - Stati Uniti d'America	490
RU - Federazione Russa	438
SG - Singapore	169
BR - Brasile	107
CN - Cina	86
HK - Hong Kong	51
IE - Irlanda	43
VN - Vietnam	33
SE - Svezia	30
IT - Italia	28
DE - Germania	18
GB - Regno Unito	14
CA - Canada	13
FR - Francia	13
IN - India	10
FI - Finlandia	9
BD - Bangladesh	8
AR - Argentina	7
PK - Pakistan	7
TR - Turchia	7
NL - Olanda	6
PL - Polonia	6
ZA - Sudafrica	6
BE - Belgio	4
AL - Albania	3
CL - Cile	3
ES - Italia	3
JM - Giamaica	3
JP - Giappone	3
KG - Kirghizistan	3
MX - Messico	3
AT - Austria	2
AU - Australia	2
BO - Bolivia	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
IQ - Iraq	2
LB - Libano	2
PY - Paraguay	2
UZ - Uzbekistan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BS - Bahamas	1
BY - Bielorussia	1
CO - Colombia	1
CY - Cipro	1
EG - Egitto	1
GE - Georgia	1
GT - Guatemala	1
ID - Indonesia	1
IL - Israele	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LC - Santa Lucia	1
LK - Sri Lanka	1
MA - Marocco	1
MY - Malesia	1
NI - Nicaragua	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
QA - Qatar	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
TO - Tonga	1
TV - Tuvalu	1
Totale	1.672

Nome	#
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors	200
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis	163
From autoinflammation to autoimmunity: old and recent findings	124
One year in review 2019: fibromyalgia	123
Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review	119
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study	118
Study of entheses in patients with spondyloarthritis and inflammatory bowel disease with and without fibromyalgia: The importance of ultrasonography	99
The effect of drugs used in rheumatology for treating SARS-CoV2 infection	98
Concerns about the safety of anti-TNF agents when treating rheumatic diseases	97
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases	95
One year in review 2021: fibromyalgia	82
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis	79
Toxicological considerations in the treatment of axial spondylo-arthritis	79
The rheumatology drugs for COVID-19 management: Which and when?	77
Behçet disease: From pathogenesis to novel therapeutic options	73
Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab	71
Totale	1.697

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	36	0	0	0	1	0	0	3	2	0	9	1	20
2022/2023	130	9	10	11	10	10	10	1	10	53	1	3	2
2023/2024	65	2	4	10	4	8	34	0	0	0	2	0	1
2024/2025	354	8	3	3	22	5	21	21	58	71	31	48	63
2025/2026	937	37	60	49	56	84	223	108	123	100	53	21	23
2026/2027	113	16	32	38	27	0	0	0	0	0	0	0	0
Totale													1.697